Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study

Author(s):  
Dan Tang ◽  
Miao Yan ◽  
Bai‐li Song ◽  
Yi‐chang Zhao ◽  
Yi‐wen Xiao ◽  
...  
Pathogens ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 812
Author(s):  
Fernando Salvador ◽  
Ana Lucas-Dato ◽  
Silvia Roure ◽  
Marta Arsuaga ◽  
Asunción Pérez-Jacoiste ◽  
...  

Strongyloidiasis affects an estimated 600 million people worldwide, especially in tropical and subtropical areas. Single-dose ivermectin treatment has shown to be effective among immunocompetent patients with uncomplicated strongyloidiasis. Here, we present the protocol of the ImmunoStrong study, a prospective observational study aiming to evaluate the effectiveness and safety of a single-dose ivermectin for treatment of uncomplicated strongyloidiasis in immunosuppressed patients. The secondary objectives are to assess accuracy of molecular techniques for the follow-up of these patients and to determine the population pharmacokinetics of ivermectin. The information retrieved by this study will cover relevant information gaps in the strongyloidiasis management among immunosuppressed patients.


2009 ◽  
Author(s):  
Ihori Kobayashi ◽  
Brian Hall ◽  
Courtney Hout ◽  
Vanessa Springston ◽  
Patrick Palmieri

2009 ◽  
Vol 36 (S 02) ◽  
Author(s):  
B Hotter ◽  
S Pittl ◽  
M Ebinger ◽  
G Oepen ◽  
K Jegzentis ◽  
...  

2019 ◽  
Author(s):  
Marianna Minnetti ◽  
Valeria Hasenmajer ◽  
Emilia Sbardella ◽  
Francesco Angelini ◽  
Ilaria Bonaventura ◽  
...  

Author(s):  
Francesca Corzani ◽  
Carolina Cecchetti ◽  
Claudia Oriolo ◽  
Paola Altieri ◽  
Annamaria Perri ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 66-LB ◽  
Author(s):  
OTHMAR MOSER ◽  
MAX L. ECKSTEIN ◽  
OLIVIA MCCARTHY ◽  
MICHAEL RIDDELL ◽  
FEDERICO Y. FONTANA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document